5
Case Report 1027 Staghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis Min Gyun Kim, Jai Hyun Chung, In Sung Hwang, C One Cho, Yong Il Park, Ji Hyeong Yu, Luck Hee Sung, Jae Yong Chung, Choong Hee Noh, Hyun Jung Kim 1 From the Departments of Urology and 1 Pathology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea Longstanding, unrecognized staghorn stones remain a major cause of morbidity in the form of pain, infection, and functional impairment of the affected kidney. Squamous cell carcinoma of the upper urinary tract is associated with stone disease and chronic infection, but the association with transitional cell carcinoma (TCC) has not been proven. We report a case of a 73-year-old man presenting with right flank pain with episodes of total gross hematuria for 1 year. An abdominopelvic computed tomo- graphy scan showed decreased parenchymal enhancement and staghorn stones in the right renal pelvis and multiple tiny calyceal stones with severe hydronephrosis. The patient underwent a simple nephrectomy. Histopathologic analysis revealed staghorn stones combined with high- grade papillary TCC of the renal pelvis. The tumor was extended into the peripelvic fat and renal parenchyme (pT3NoMo). (Korean J Urol 2009; 50:1027-1031) Key Words: Transitional cell carcinoma, Kidney pelvis Korean Journal of Urology Vol. 50 No. 10: 1027-1031, October 2009 DOI: 10.4111/kju.2009.50.10.1027 ReceivedJune 23, 2009 AcceptedSeptember 16, 2009 Correspondence to: Luck Hee Sung Department of Urology, Inje University College of Medicine, 761-1, Sanggye 7-dong, Nowon-gu, Seoul 139-707, Korea TEL: 02-950-1139 FAX: 02-939-6113 E-mail: [email protected] The Korean Urological Association, 2009 Kim et al reported that urothelial cell carcinoma of the upper urinary tract accounts for approximately 6.0% to 7.5% of all urologic malignancies and is roughly three times more common in men than in women; the incidence rate was 0.86 to 1.21 per 100,000 persons in Korea between 1998 to 2002 [1]. Transitional cell carcinoma (TCC) makes up more than 90% of upper urinary tract tumors, followed by squamous cell carcinoma (SCC). Longstanding staghorn stones result in functional impairment of the affected kidney. Chronic infection associated with stone disease and obstruction has been related to the development of upper urinary tract SCC. It is presumed that chronic irritation of the urothelium may result in squamous metaplasia, which can later develop into SCC [2]. On the other hand, the association between staghorn stones and TCC of the renal pelvis has rarely been documented. Preoperative diagnosis of such lesions may be difficult because of the presence of a staghorn stone and the inflammatory process. Here we present the case of one patient who had staghorn stones and chronic renal obstruction combined with a papillary TCC of the renal pelvis. CASE REPORT A 73-year-old man was referred to the Sanggye Paik Hospital Emergency Center for evaluation of dizziness and general weakness. He also presented with intermittent, blunt, right flank pain and total gross hematuria lasting 1 year. He was a nonsmoker with no history of urolithiasis. He had hypertension and a previous cardiovascular accident as co-morbid conditions two years ago. A soft mass was palpable in the right flank area by a bimanual examination. Complete blood count, urine analysis, urine culture, and routine chemistry were done. The patient’s initial hemoglobin was 6.9 g/dl and his serum creatinine was 2.3 mg/dl. Urine analysis showed many red blood cell (RBC)/10-29 white blood cell (WBC) on high-power fields

Staghorn Stones Combined with Transitional Cell … Report 1027 Staghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis Min Gyun Kim, Jai Hyun Chung, In Sung

Embed Size (px)

Citation preview

Case Report

1027

Staghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis

Min Gyun Kim Jai Hyun Chung In Sung Hwang C One Cho Yong Il Park Ji Hyeong Yu Luck Hee Sung Jae Yong Chung Choong Hee Noh Hyun Jung Kim1

From the Departments of Urology and 1Pathology Sanggye Paik Hospital Inje University College of Medicine Seoul Korea

Longstanding unrecognized staghorn stones remain a major cause of morbidity in the form of pain infection and functional impairment of the affected kidney Squamous cell carcinoma of the upper urinary tract is associated with stone disease and chronic infection but the association with transitional cell carcinoma (TCC) has not been proven We report a case of a 73-year-old man presenting with right flank pain with episodes of total gross hematuria for 1 year An abdominopelvic computed tomo-graphy scan showed decreased parenchymal enhancement and staghorn stones in the right renal pelvis and multiple tiny calyceal stones with severe hydronephrosis The patient underwent a simple nephrectomy Histopathologic analysis revealed staghorn stones combined with high- grade papillary TCC of the renal pelvis The tumor was extended into the peripelvic fat and renal parenchyme (pT3NoMo) (Korean J Urol 2009 501027-1031)985103985103985103985103985103985103985103985103985103985103985103985103985103985103985103985103985103985103985103985103Key Words Transitional cell carcinoma Kidney pelvis

Korean Journal of Urology Vol 50 No 10 1027-1031 October 2009

DOI 104111kju200950101027

ReceivedJune 23 2009AcceptedSeptember 16 2009

Correspondence to Luck Hee SungDepartment of Urology Inje University College of Medicine 761-1 Sanggye 7-dong Nowon-gu Seoul 139-707 KoreaTEL 02-950-1139FAX 02-939-6113E-mail uroman1yahoocom

The Korean Urological Association 2009

Kim et al reported that urothelial cell carcinoma of the upper

urinary tract accounts for approximately 60 to 75 of all

urologic malignancies and is roughly three times more common

in men than in women the incidence rate was 086 to 121 per

100000 persons in Korea between 1998 to 2002 [1]

Transitional cell carcinoma (TCC) makes up more than 90

of upper urinary tract tumors followed by squamous cell

carcinoma (SCC)

Longstanding staghorn stones result in functional impairment

of the affected kidney Chronic infection associated with stone

disease and obstruction has been related to the development of

upper urinary tract SCC It is presumed that chronic irritation

of the urothelium may result in squamous metaplasia which

can later develop into SCC [2]

On the other hand the association between staghorn stones

and TCC of the renal pelvis has rarely been documented

Preoperative diagnosis of such lesions may be difficult because

of the presence of a staghorn stone and the inflammatory

process

 Here we present the case of one patient who had staghorn

stones and chronic renal obstruction combined with a papillary

TCC of the renal pelvis

CASE REPORT

A 73-year-old man was referred to the Sanggye Paik Hospital

Emergency Center for evaluation of dizziness and general

weakness He also presented with intermittent blunt right flank

pain and total gross hematuria lasting 1 year He was a

nonsmoker with no history of urolithiasis He had hypertension

and a previous cardiovascular accident as co-morbid conditions

two years ago

A soft mass was palpable in the right flank area by a

bimanual examination Complete blood count urine analysis

urine culture and routine chemistry were done The patientrsquos

initial hemoglobin was 69 gdl and his serum creatinine was

23 mgdl Urine analysis showed many red blood cell

(RBC)10-29 white blood cell (WBC) on high-power fields

1028 Korean Journal of Urology vol 50 1027-1031 October 2009

Fig 1 KUB showing a staghorn stone in the right pelvis and

multiple calyceal stones in a 73-year-old man

Fig 2 Abdominopelvic CT scan showing severe hydronephrosis with diffuse cortical thinning (A) and decreased renal parenchymal

enhancement around the staghorn stones in the arterial phase (B)

(HPF) and the urine culture was sterile Urine cytology showed

no abnormal cells Plain film (KUB) radiography showed a 4x4

cm and 4x25 cm sized calcification and sand-like calcification

on the right upper quadrant (Fig 1)

Staghorn stones in the right renal pelvis and multiple calyceal

stones with severe hydronephrosis were detected by abdominal

ultrasonography but the left kidney was in the normal range

After conservative treatment (eg blood transfusions and

hydrations) the patientrsquos serum creatinine level was reduced to

17 mgdl Abdominopelvic computed tomography (CT) showed

staghorn stones in the right pelvis and multiple tiny calyceal

stones with severe hydronephrosis The CT scan also showed

decreased renal parenchymal enhancement around the stones

and diffuse cortical thinning with fluid collection (Fig 2) No

renal vein thrombi or enlarged lymph nodes were found

Therefore we did not suspect any malignancy on these

radiologic images

In these examinations we concluded staghorn stones and

calyceal stones were associated with the poorly functioning

kidney We performed a simple nephrectomy In the operative

field the enlarged cystic-shaped right kidney was dark colored

and easily dissected (Fig 3) The histopathology demonstrated

high-grade (WHO 2004) papillary TCC approximately 10 cm

in its greatest dimension with extension to the peripelvic fat

and the full thickness of the renal parenchyma (pT3) (Fig 4)

The ureteral resection margin was involved with carcinoma

The patient refused a further operation for a ureteral stump

resection He was treated with two cycles of systemic chemo-

therapy with gemcitabine and carboplatin instead of cisplatin

because of his lower creatinine clearance rate (42 mlmin)

DISCUSSION

Staghorn stones are primarily composed of mixtures of

struvite (magnesium ammonium phosphate) and calcium carbo-

nate apatite These stones are typically associated with urinary

tract infections with urea-splitting organisms and are referred

Min Gyun Kim et alStaghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis 1029

Fig 3 Gross appearance (A) A staghorn stone (arrow 4x28x18 cm) is impacted in the pelvis with marked cystic dilatation of the

inflamed pelvo-calyceal system the other dilated spaces are filled with numerous small brownish stones (asterisk) (B) The pelvo-calyceal

wall is thickened with a whitish granular tumor growth and mucosal papillary protrusions after formalin-fixation (arrows)

Fig 4 Microscopic appearance (A) Some mucosal surface shows papillary nodularity (HampE x10) The tumor extends to the full depth

of the renal parenchyma through the pelvic wall (T3) (B) The medium power view shows a thin and delicate papillary core with attached

urothelial cells with moderate differentiation (HampE x40)

to as infection stones Over time untreated staghorn stones may

lead to deterioration of renal function pyelonephritis flank

pain end-stage renal disease and life-threatening urosepsis may

rarely be associated with urothelial carcinoma [3-7]

Raghavendran et al reported 18 patients with renal pelvis

malignancies associated with a long history of staghorn stone

disease (mean 88 years) with a non-visualized kidney on

intravenous urogram [4] A high incidence of SCC (1518) was

noted followed by 2 TCCs and 1 adenocarcinoma (AC) The

two patients with gross hematuria were diagnosed with a tumor

in preoperative imaging (CT) and underwent radical nephrec-

tomy On the other hand 16 patients who underwent simple

nephrectomy were found to have malignancy postoperatively on

histological examinations of the nephrectomized specimens

Those authors suggested that the presence of gross hematuria

in these patients should raise suspicion of a renal tumor and

necessitate further imaging study such as CT They suggested

a hypothesis that urothelial hyperplasia can evolve into frank

TCC or it can become dysplastic due to further irritation and

dedifferentiate into SCC and AC At present we cannot defini-

1030 Korean Journal of Urology vol 50 1027-1031 October 2009

tely say that there is a strong association between stones and

TCC but further studies are needed to prove this possible

association Although our patient presented a chief complaint

of gross hematuria we did not suspect a urothelial tumor on

radiologic imaging (ultrasonography and CT) except for sta-

ghorn stones with severe hydronephrosis

Katz et al reported that 3 cases of 500 percutaneous

nephrolithotomies were revealed to have unexpected urothelial

carcinoma of the renal pelvis during or after percutaneous stone

removal [5] All 3 patients had a longstanding history of stone

disease and urinary infection They all died from metastatic

disease within 2-19 months after the diagnosis of urothelial

cancer In this literature radiological investigations are not

diagnostic because of reactive fibrosis and post-obstructive

inflammatory changes [6] It is common to miss an associated

urothelial tumor in these patients preoperatively so the prog-

nosis is poor

The prevalence of malignancy associated with a nonfunc-

tioning kidney caused by stone disease remains unclear Yeh

et al reported that 24 of 47 (510) patients who underwent

nephrectomy to treat a nonfunctioning kidney caused by stone

disease were revealed to have a high incidence of malignancy

such as 17 TCCs 5 renal cell carcinomas 1 SCC and 1

epidermoid carcinoma [7] Malignancy was suspected in only

7 patients in preoperative imaging studies and postoperative

diagnosis of TCC was most common although previous studies

have reported a high proportion of SCC associated with

nonfunctioning kidneys Those authors suggested that surgical

specimens be taken to pathology for careful evaluation during

surgery in order to evaluate whether a more invasive surgery

such as nephroureterectomy is necessary

TCC of upper tract tumors may show up as papillary or

sessile lesions and may be unifocal or multifocal On histologic

examination these lesions are similar to TCC of the bladder

but the relative thinness of the muscle layer of the renal pelvis

makes invasion through the muscle coat an earlier event

Progression to muscle invasion or invasion into the renal

parenchyma may be more likely to occur [8] Clinical outcomes

are most highly dependent on pathologic stage and grade

Locally advanced upper tract urothelial carcinoma has a poor

prognosis because of the high risk of systemic recurrence

Therefore there is a need for effective adjuvant therapies for

patients with locally advanced or metastatic disease Adjuvant

radiotherapy is of limited value in improving local disease

control or survival in patients undergoing radical surgery for

treatment of advanced TCC of the upper urinary tract [9]

Chemotherapy may provide some benefit The chemotherapy

regimens are the same as used for bladder cancer After two

cycles of systemic chemotherapy with gemcitabine and carbo-

platin during two months we will evaluate with a short-term

CT follow-up The patientrsquos prognosis will be poor due to the

renal parenchymal invasion positive ureteral resection margin

and lymphovascular invasion

Our experience and other reports in the literature suggest that

we should keep in mind the possibility of an underlying carci-

noma of the upper urinary tract in patients with a nonfunc-

tioning kidney and gross hematuria caused by stone disease

Before performing an operation on these patients preoperative

imaging studies should be carefully investigated to diagnose

any underlying carcinoma If any suspicion exists even after the

operation a frozen biopsy or postoperative specimen analysis

should be conducted to rule out carcinoma even if carcinoma

is missed preoperatively because early diagnosis is very

important for prolongation of survival

REFERENCES

1 Kim WJ Chung JI Hong JH Kim CS Jung SI Yoon DK

Epidemiological study for urologic cancer in Korea (1998-

2002) Korean J Urol 2004451081-8

2 Holmaumlng S Lele SM Johansson SL Squamous cell carcinoma

of the renal pelvis and ureter incidence symptoms treatment

and outcome J Urol 200717851-6

3 Preminger GM Assimos DG Lingeman JE Nakada SY Pearle

MS Wolf JS Jr Chapter 1 AUA guideline on management of

staghorn calculi diagnosis and treatment recommendations J

Urol 20051731991-2000

4 Raghavendran M Rastogi A Dubey D Chaudhary H Kumar

A Srivastava A et al Stones associated renal pelvic mali-

gnancies Indian J Cancer 200340108-12

5 Katz R Gofrit ON Golijanin D Landau EH Shapiro A Pode

D et al Urothelial cancer of the renal pelvis in percutaneous

nephrolithotomy patients Urol Int 20057517-20

6 Cholankeril JV Freundlich R Ketyer S Spirito AL Napolitano

J Computed tomography in urothelial tumors of renal pelvis

and related filling defects J Comput Tomogr 198610263-72

7 Yeh CC Lin TH Wu HC Chang CH Chen CC Chen WC

A high association of upper urinary tract transitional cell

carcinoma with nonfunctioning kidney caused by stone disease

in Taiwan Urol Int 20077919-23

8 Robert CF Urothelial tumors of the upper urinary tract In

Wein AJ Kovoussi LR Novick AC Partin AW Peters CA

Min Gyun Kim et alStaghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis 1031

editors Campbell-Walsh urology 9th ed Philadelphia Saun-

ders 20071643

9 Hall MC Womack JS Roehrborn CG Carmody T Sagalowsky

AI Advanced transitional cell carcinoma of the upper urinary

tract patterns of failure survival and impact of postoperative

adjuvant radiotherapy J Urol 1998160703-6

1028 Korean Journal of Urology vol 50 1027-1031 October 2009

Fig 1 KUB showing a staghorn stone in the right pelvis and

multiple calyceal stones in a 73-year-old man

Fig 2 Abdominopelvic CT scan showing severe hydronephrosis with diffuse cortical thinning (A) and decreased renal parenchymal

enhancement around the staghorn stones in the arterial phase (B)

(HPF) and the urine culture was sterile Urine cytology showed

no abnormal cells Plain film (KUB) radiography showed a 4x4

cm and 4x25 cm sized calcification and sand-like calcification

on the right upper quadrant (Fig 1)

Staghorn stones in the right renal pelvis and multiple calyceal

stones with severe hydronephrosis were detected by abdominal

ultrasonography but the left kidney was in the normal range

After conservative treatment (eg blood transfusions and

hydrations) the patientrsquos serum creatinine level was reduced to

17 mgdl Abdominopelvic computed tomography (CT) showed

staghorn stones in the right pelvis and multiple tiny calyceal

stones with severe hydronephrosis The CT scan also showed

decreased renal parenchymal enhancement around the stones

and diffuse cortical thinning with fluid collection (Fig 2) No

renal vein thrombi or enlarged lymph nodes were found

Therefore we did not suspect any malignancy on these

radiologic images

In these examinations we concluded staghorn stones and

calyceal stones were associated with the poorly functioning

kidney We performed a simple nephrectomy In the operative

field the enlarged cystic-shaped right kidney was dark colored

and easily dissected (Fig 3) The histopathology demonstrated

high-grade (WHO 2004) papillary TCC approximately 10 cm

in its greatest dimension with extension to the peripelvic fat

and the full thickness of the renal parenchyma (pT3) (Fig 4)

The ureteral resection margin was involved with carcinoma

The patient refused a further operation for a ureteral stump

resection He was treated with two cycles of systemic chemo-

therapy with gemcitabine and carboplatin instead of cisplatin

because of his lower creatinine clearance rate (42 mlmin)

DISCUSSION

Staghorn stones are primarily composed of mixtures of

struvite (magnesium ammonium phosphate) and calcium carbo-

nate apatite These stones are typically associated with urinary

tract infections with urea-splitting organisms and are referred

Min Gyun Kim et alStaghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis 1029

Fig 3 Gross appearance (A) A staghorn stone (arrow 4x28x18 cm) is impacted in the pelvis with marked cystic dilatation of the

inflamed pelvo-calyceal system the other dilated spaces are filled with numerous small brownish stones (asterisk) (B) The pelvo-calyceal

wall is thickened with a whitish granular tumor growth and mucosal papillary protrusions after formalin-fixation (arrows)

Fig 4 Microscopic appearance (A) Some mucosal surface shows papillary nodularity (HampE x10) The tumor extends to the full depth

of the renal parenchyma through the pelvic wall (T3) (B) The medium power view shows a thin and delicate papillary core with attached

urothelial cells with moderate differentiation (HampE x40)

to as infection stones Over time untreated staghorn stones may

lead to deterioration of renal function pyelonephritis flank

pain end-stage renal disease and life-threatening urosepsis may

rarely be associated with urothelial carcinoma [3-7]

Raghavendran et al reported 18 patients with renal pelvis

malignancies associated with a long history of staghorn stone

disease (mean 88 years) with a non-visualized kidney on

intravenous urogram [4] A high incidence of SCC (1518) was

noted followed by 2 TCCs and 1 adenocarcinoma (AC) The

two patients with gross hematuria were diagnosed with a tumor

in preoperative imaging (CT) and underwent radical nephrec-

tomy On the other hand 16 patients who underwent simple

nephrectomy were found to have malignancy postoperatively on

histological examinations of the nephrectomized specimens

Those authors suggested that the presence of gross hematuria

in these patients should raise suspicion of a renal tumor and

necessitate further imaging study such as CT They suggested

a hypothesis that urothelial hyperplasia can evolve into frank

TCC or it can become dysplastic due to further irritation and

dedifferentiate into SCC and AC At present we cannot defini-

1030 Korean Journal of Urology vol 50 1027-1031 October 2009

tely say that there is a strong association between stones and

TCC but further studies are needed to prove this possible

association Although our patient presented a chief complaint

of gross hematuria we did not suspect a urothelial tumor on

radiologic imaging (ultrasonography and CT) except for sta-

ghorn stones with severe hydronephrosis

Katz et al reported that 3 cases of 500 percutaneous

nephrolithotomies were revealed to have unexpected urothelial

carcinoma of the renal pelvis during or after percutaneous stone

removal [5] All 3 patients had a longstanding history of stone

disease and urinary infection They all died from metastatic

disease within 2-19 months after the diagnosis of urothelial

cancer In this literature radiological investigations are not

diagnostic because of reactive fibrosis and post-obstructive

inflammatory changes [6] It is common to miss an associated

urothelial tumor in these patients preoperatively so the prog-

nosis is poor

The prevalence of malignancy associated with a nonfunc-

tioning kidney caused by stone disease remains unclear Yeh

et al reported that 24 of 47 (510) patients who underwent

nephrectomy to treat a nonfunctioning kidney caused by stone

disease were revealed to have a high incidence of malignancy

such as 17 TCCs 5 renal cell carcinomas 1 SCC and 1

epidermoid carcinoma [7] Malignancy was suspected in only

7 patients in preoperative imaging studies and postoperative

diagnosis of TCC was most common although previous studies

have reported a high proportion of SCC associated with

nonfunctioning kidneys Those authors suggested that surgical

specimens be taken to pathology for careful evaluation during

surgery in order to evaluate whether a more invasive surgery

such as nephroureterectomy is necessary

TCC of upper tract tumors may show up as papillary or

sessile lesions and may be unifocal or multifocal On histologic

examination these lesions are similar to TCC of the bladder

but the relative thinness of the muscle layer of the renal pelvis

makes invasion through the muscle coat an earlier event

Progression to muscle invasion or invasion into the renal

parenchyma may be more likely to occur [8] Clinical outcomes

are most highly dependent on pathologic stage and grade

Locally advanced upper tract urothelial carcinoma has a poor

prognosis because of the high risk of systemic recurrence

Therefore there is a need for effective adjuvant therapies for

patients with locally advanced or metastatic disease Adjuvant

radiotherapy is of limited value in improving local disease

control or survival in patients undergoing radical surgery for

treatment of advanced TCC of the upper urinary tract [9]

Chemotherapy may provide some benefit The chemotherapy

regimens are the same as used for bladder cancer After two

cycles of systemic chemotherapy with gemcitabine and carbo-

platin during two months we will evaluate with a short-term

CT follow-up The patientrsquos prognosis will be poor due to the

renal parenchymal invasion positive ureteral resection margin

and lymphovascular invasion

Our experience and other reports in the literature suggest that

we should keep in mind the possibility of an underlying carci-

noma of the upper urinary tract in patients with a nonfunc-

tioning kidney and gross hematuria caused by stone disease

Before performing an operation on these patients preoperative

imaging studies should be carefully investigated to diagnose

any underlying carcinoma If any suspicion exists even after the

operation a frozen biopsy or postoperative specimen analysis

should be conducted to rule out carcinoma even if carcinoma

is missed preoperatively because early diagnosis is very

important for prolongation of survival

REFERENCES

1 Kim WJ Chung JI Hong JH Kim CS Jung SI Yoon DK

Epidemiological study for urologic cancer in Korea (1998-

2002) Korean J Urol 2004451081-8

2 Holmaumlng S Lele SM Johansson SL Squamous cell carcinoma

of the renal pelvis and ureter incidence symptoms treatment

and outcome J Urol 200717851-6

3 Preminger GM Assimos DG Lingeman JE Nakada SY Pearle

MS Wolf JS Jr Chapter 1 AUA guideline on management of

staghorn calculi diagnosis and treatment recommendations J

Urol 20051731991-2000

4 Raghavendran M Rastogi A Dubey D Chaudhary H Kumar

A Srivastava A et al Stones associated renal pelvic mali-

gnancies Indian J Cancer 200340108-12

5 Katz R Gofrit ON Golijanin D Landau EH Shapiro A Pode

D et al Urothelial cancer of the renal pelvis in percutaneous

nephrolithotomy patients Urol Int 20057517-20

6 Cholankeril JV Freundlich R Ketyer S Spirito AL Napolitano

J Computed tomography in urothelial tumors of renal pelvis

and related filling defects J Comput Tomogr 198610263-72

7 Yeh CC Lin TH Wu HC Chang CH Chen CC Chen WC

A high association of upper urinary tract transitional cell

carcinoma with nonfunctioning kidney caused by stone disease

in Taiwan Urol Int 20077919-23

8 Robert CF Urothelial tumors of the upper urinary tract In

Wein AJ Kovoussi LR Novick AC Partin AW Peters CA

Min Gyun Kim et alStaghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis 1031

editors Campbell-Walsh urology 9th ed Philadelphia Saun-

ders 20071643

9 Hall MC Womack JS Roehrborn CG Carmody T Sagalowsky

AI Advanced transitional cell carcinoma of the upper urinary

tract patterns of failure survival and impact of postoperative

adjuvant radiotherapy J Urol 1998160703-6

Min Gyun Kim et alStaghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis 1029

Fig 3 Gross appearance (A) A staghorn stone (arrow 4x28x18 cm) is impacted in the pelvis with marked cystic dilatation of the

inflamed pelvo-calyceal system the other dilated spaces are filled with numerous small brownish stones (asterisk) (B) The pelvo-calyceal

wall is thickened with a whitish granular tumor growth and mucosal papillary protrusions after formalin-fixation (arrows)

Fig 4 Microscopic appearance (A) Some mucosal surface shows papillary nodularity (HampE x10) The tumor extends to the full depth

of the renal parenchyma through the pelvic wall (T3) (B) The medium power view shows a thin and delicate papillary core with attached

urothelial cells with moderate differentiation (HampE x40)

to as infection stones Over time untreated staghorn stones may

lead to deterioration of renal function pyelonephritis flank

pain end-stage renal disease and life-threatening urosepsis may

rarely be associated with urothelial carcinoma [3-7]

Raghavendran et al reported 18 patients with renal pelvis

malignancies associated with a long history of staghorn stone

disease (mean 88 years) with a non-visualized kidney on

intravenous urogram [4] A high incidence of SCC (1518) was

noted followed by 2 TCCs and 1 adenocarcinoma (AC) The

two patients with gross hematuria were diagnosed with a tumor

in preoperative imaging (CT) and underwent radical nephrec-

tomy On the other hand 16 patients who underwent simple

nephrectomy were found to have malignancy postoperatively on

histological examinations of the nephrectomized specimens

Those authors suggested that the presence of gross hematuria

in these patients should raise suspicion of a renal tumor and

necessitate further imaging study such as CT They suggested

a hypothesis that urothelial hyperplasia can evolve into frank

TCC or it can become dysplastic due to further irritation and

dedifferentiate into SCC and AC At present we cannot defini-

1030 Korean Journal of Urology vol 50 1027-1031 October 2009

tely say that there is a strong association between stones and

TCC but further studies are needed to prove this possible

association Although our patient presented a chief complaint

of gross hematuria we did not suspect a urothelial tumor on

radiologic imaging (ultrasonography and CT) except for sta-

ghorn stones with severe hydronephrosis

Katz et al reported that 3 cases of 500 percutaneous

nephrolithotomies were revealed to have unexpected urothelial

carcinoma of the renal pelvis during or after percutaneous stone

removal [5] All 3 patients had a longstanding history of stone

disease and urinary infection They all died from metastatic

disease within 2-19 months after the diagnosis of urothelial

cancer In this literature radiological investigations are not

diagnostic because of reactive fibrosis and post-obstructive

inflammatory changes [6] It is common to miss an associated

urothelial tumor in these patients preoperatively so the prog-

nosis is poor

The prevalence of malignancy associated with a nonfunc-

tioning kidney caused by stone disease remains unclear Yeh

et al reported that 24 of 47 (510) patients who underwent

nephrectomy to treat a nonfunctioning kidney caused by stone

disease were revealed to have a high incidence of malignancy

such as 17 TCCs 5 renal cell carcinomas 1 SCC and 1

epidermoid carcinoma [7] Malignancy was suspected in only

7 patients in preoperative imaging studies and postoperative

diagnosis of TCC was most common although previous studies

have reported a high proportion of SCC associated with

nonfunctioning kidneys Those authors suggested that surgical

specimens be taken to pathology for careful evaluation during

surgery in order to evaluate whether a more invasive surgery

such as nephroureterectomy is necessary

TCC of upper tract tumors may show up as papillary or

sessile lesions and may be unifocal or multifocal On histologic

examination these lesions are similar to TCC of the bladder

but the relative thinness of the muscle layer of the renal pelvis

makes invasion through the muscle coat an earlier event

Progression to muscle invasion or invasion into the renal

parenchyma may be more likely to occur [8] Clinical outcomes

are most highly dependent on pathologic stage and grade

Locally advanced upper tract urothelial carcinoma has a poor

prognosis because of the high risk of systemic recurrence

Therefore there is a need for effective adjuvant therapies for

patients with locally advanced or metastatic disease Adjuvant

radiotherapy is of limited value in improving local disease

control or survival in patients undergoing radical surgery for

treatment of advanced TCC of the upper urinary tract [9]

Chemotherapy may provide some benefit The chemotherapy

regimens are the same as used for bladder cancer After two

cycles of systemic chemotherapy with gemcitabine and carbo-

platin during two months we will evaluate with a short-term

CT follow-up The patientrsquos prognosis will be poor due to the

renal parenchymal invasion positive ureteral resection margin

and lymphovascular invasion

Our experience and other reports in the literature suggest that

we should keep in mind the possibility of an underlying carci-

noma of the upper urinary tract in patients with a nonfunc-

tioning kidney and gross hematuria caused by stone disease

Before performing an operation on these patients preoperative

imaging studies should be carefully investigated to diagnose

any underlying carcinoma If any suspicion exists even after the

operation a frozen biopsy or postoperative specimen analysis

should be conducted to rule out carcinoma even if carcinoma

is missed preoperatively because early diagnosis is very

important for prolongation of survival

REFERENCES

1 Kim WJ Chung JI Hong JH Kim CS Jung SI Yoon DK

Epidemiological study for urologic cancer in Korea (1998-

2002) Korean J Urol 2004451081-8

2 Holmaumlng S Lele SM Johansson SL Squamous cell carcinoma

of the renal pelvis and ureter incidence symptoms treatment

and outcome J Urol 200717851-6

3 Preminger GM Assimos DG Lingeman JE Nakada SY Pearle

MS Wolf JS Jr Chapter 1 AUA guideline on management of

staghorn calculi diagnosis and treatment recommendations J

Urol 20051731991-2000

4 Raghavendran M Rastogi A Dubey D Chaudhary H Kumar

A Srivastava A et al Stones associated renal pelvic mali-

gnancies Indian J Cancer 200340108-12

5 Katz R Gofrit ON Golijanin D Landau EH Shapiro A Pode

D et al Urothelial cancer of the renal pelvis in percutaneous

nephrolithotomy patients Urol Int 20057517-20

6 Cholankeril JV Freundlich R Ketyer S Spirito AL Napolitano

J Computed tomography in urothelial tumors of renal pelvis

and related filling defects J Comput Tomogr 198610263-72

7 Yeh CC Lin TH Wu HC Chang CH Chen CC Chen WC

A high association of upper urinary tract transitional cell

carcinoma with nonfunctioning kidney caused by stone disease

in Taiwan Urol Int 20077919-23

8 Robert CF Urothelial tumors of the upper urinary tract In

Wein AJ Kovoussi LR Novick AC Partin AW Peters CA

Min Gyun Kim et alStaghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis 1031

editors Campbell-Walsh urology 9th ed Philadelphia Saun-

ders 20071643

9 Hall MC Womack JS Roehrborn CG Carmody T Sagalowsky

AI Advanced transitional cell carcinoma of the upper urinary

tract patterns of failure survival and impact of postoperative

adjuvant radiotherapy J Urol 1998160703-6

1030 Korean Journal of Urology vol 50 1027-1031 October 2009

tely say that there is a strong association between stones and

TCC but further studies are needed to prove this possible

association Although our patient presented a chief complaint

of gross hematuria we did not suspect a urothelial tumor on

radiologic imaging (ultrasonography and CT) except for sta-

ghorn stones with severe hydronephrosis

Katz et al reported that 3 cases of 500 percutaneous

nephrolithotomies were revealed to have unexpected urothelial

carcinoma of the renal pelvis during or after percutaneous stone

removal [5] All 3 patients had a longstanding history of stone

disease and urinary infection They all died from metastatic

disease within 2-19 months after the diagnosis of urothelial

cancer In this literature radiological investigations are not

diagnostic because of reactive fibrosis and post-obstructive

inflammatory changes [6] It is common to miss an associated

urothelial tumor in these patients preoperatively so the prog-

nosis is poor

The prevalence of malignancy associated with a nonfunc-

tioning kidney caused by stone disease remains unclear Yeh

et al reported that 24 of 47 (510) patients who underwent

nephrectomy to treat a nonfunctioning kidney caused by stone

disease were revealed to have a high incidence of malignancy

such as 17 TCCs 5 renal cell carcinomas 1 SCC and 1

epidermoid carcinoma [7] Malignancy was suspected in only

7 patients in preoperative imaging studies and postoperative

diagnosis of TCC was most common although previous studies

have reported a high proportion of SCC associated with

nonfunctioning kidneys Those authors suggested that surgical

specimens be taken to pathology for careful evaluation during

surgery in order to evaluate whether a more invasive surgery

such as nephroureterectomy is necessary

TCC of upper tract tumors may show up as papillary or

sessile lesions and may be unifocal or multifocal On histologic

examination these lesions are similar to TCC of the bladder

but the relative thinness of the muscle layer of the renal pelvis

makes invasion through the muscle coat an earlier event

Progression to muscle invasion or invasion into the renal

parenchyma may be more likely to occur [8] Clinical outcomes

are most highly dependent on pathologic stage and grade

Locally advanced upper tract urothelial carcinoma has a poor

prognosis because of the high risk of systemic recurrence

Therefore there is a need for effective adjuvant therapies for

patients with locally advanced or metastatic disease Adjuvant

radiotherapy is of limited value in improving local disease

control or survival in patients undergoing radical surgery for

treatment of advanced TCC of the upper urinary tract [9]

Chemotherapy may provide some benefit The chemotherapy

regimens are the same as used for bladder cancer After two

cycles of systemic chemotherapy with gemcitabine and carbo-

platin during two months we will evaluate with a short-term

CT follow-up The patientrsquos prognosis will be poor due to the

renal parenchymal invasion positive ureteral resection margin

and lymphovascular invasion

Our experience and other reports in the literature suggest that

we should keep in mind the possibility of an underlying carci-

noma of the upper urinary tract in patients with a nonfunc-

tioning kidney and gross hematuria caused by stone disease

Before performing an operation on these patients preoperative

imaging studies should be carefully investigated to diagnose

any underlying carcinoma If any suspicion exists even after the

operation a frozen biopsy or postoperative specimen analysis

should be conducted to rule out carcinoma even if carcinoma

is missed preoperatively because early diagnosis is very

important for prolongation of survival

REFERENCES

1 Kim WJ Chung JI Hong JH Kim CS Jung SI Yoon DK

Epidemiological study for urologic cancer in Korea (1998-

2002) Korean J Urol 2004451081-8

2 Holmaumlng S Lele SM Johansson SL Squamous cell carcinoma

of the renal pelvis and ureter incidence symptoms treatment

and outcome J Urol 200717851-6

3 Preminger GM Assimos DG Lingeman JE Nakada SY Pearle

MS Wolf JS Jr Chapter 1 AUA guideline on management of

staghorn calculi diagnosis and treatment recommendations J

Urol 20051731991-2000

4 Raghavendran M Rastogi A Dubey D Chaudhary H Kumar

A Srivastava A et al Stones associated renal pelvic mali-

gnancies Indian J Cancer 200340108-12

5 Katz R Gofrit ON Golijanin D Landau EH Shapiro A Pode

D et al Urothelial cancer of the renal pelvis in percutaneous

nephrolithotomy patients Urol Int 20057517-20

6 Cholankeril JV Freundlich R Ketyer S Spirito AL Napolitano

J Computed tomography in urothelial tumors of renal pelvis

and related filling defects J Comput Tomogr 198610263-72

7 Yeh CC Lin TH Wu HC Chang CH Chen CC Chen WC

A high association of upper urinary tract transitional cell

carcinoma with nonfunctioning kidney caused by stone disease

in Taiwan Urol Int 20077919-23

8 Robert CF Urothelial tumors of the upper urinary tract In

Wein AJ Kovoussi LR Novick AC Partin AW Peters CA

Min Gyun Kim et alStaghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis 1031

editors Campbell-Walsh urology 9th ed Philadelphia Saun-

ders 20071643

9 Hall MC Womack JS Roehrborn CG Carmody T Sagalowsky

AI Advanced transitional cell carcinoma of the upper urinary

tract patterns of failure survival and impact of postoperative

adjuvant radiotherapy J Urol 1998160703-6

Min Gyun Kim et alStaghorn Stones Combined with Transitional Cell Carcinoma of the Renal Pelvis 1031

editors Campbell-Walsh urology 9th ed Philadelphia Saun-

ders 20071643

9 Hall MC Womack JS Roehrborn CG Carmody T Sagalowsky

AI Advanced transitional cell carcinoma of the upper urinary

tract patterns of failure survival and impact of postoperative

adjuvant radiotherapy J Urol 1998160703-6